Peculiarities of the antibacterial treatment of bacterial rhinosinusitis

Antoniv V.F.; Shoniia L.I.; Efimochkina K.V.

doi:https://doi.org/

Antoniv V.F.

Kafedra otorinolaringologii Rossiĭskogo universiteta Druzhby narodov, Moskva

Shoniia L.I.

GKB #4 Departamenta zdravookhraneniia Moskvy

Efimochkina K.V.

Kafedra otorinolaringologii Rossiĭskogo universiteta Druzhby narodov, Moskva

Peculiarities of the antibacterial treatment of bacterial rhinosinusitis

Authors:

Antoniv V.F., Shoniia L.I., Efimochkina K.V.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2012;77(6): 63‑66

Read: 2871 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Antoniv VF, Shoniia LI, Shoniia LI, Efimochkina KV. Peculiarities of the antibacterial treatment of bacterial rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2012;77(6):63‑66. (In Russ.)

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Efficacy and safety of topical antibiotic therapy in patients with acute external bacterial otitis: results of a retrospective study. Russian Bulletin of Otorhinolaryngology. 2024;(6):24-27

Pneumatization of the middle turbinate and chronic sinusitis: current state of the problem and review of surgical correction. Russian Bulletin of Otorhinolaryngology. 2025;(1):69-74

Experimental and clinical evaluation of the safety and efficacy of Polydexa spray with phenylephrine in acute rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2025;(4):39-46

The role of Inflasinusans in the treatment of acute rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2025;(4):64-71

Potential applications of botulinum toxin formulations in addressing postnasal syndrome. Russian Rhinology. 2024;(4):301-307

Abstract:

The objective of the present work was to study the principal causative agents of acute bacterial rhinosinusitis (ABRS) and the mechanisms underlying the development of its relapses. The secondary objective was to consider problems related to the antibacterial treatment of this pathology and suggest approaches to their solution. The results of analysis of the causes behind relapses of acute bacterial rhinosinisitis are presented, the recommendations on the choice of antibacterial preparations are proposed.

Keywords:

antibacterial therapy

rhinosinusitis

antibacterial therapy

Authors:

Antoniv V.F.

Kafedra otorinolaringologii Rossiĭskogo universiteta Druzhby narodov, Moskva

Shoniia L.I.

GKB #4 Departamenta zdravookhraneniia Moskvy

Efimochkina K.V.

Kafedra otorinolaringologii Rossiĭskogo universiteta Druzhby narodov, Moskva

Close metadata

References:

Tarasov A.A., Kamanin E.I., Kryukov A.I., Strachunskii L.S. Ostryi bakterial'nyi rinosinusit: sovremennye podkhody k diagnostike i antibakterial'noi terapii v ambulatornykh usloviyakh. Vestn otorinolar 2003; 2: 41-45.
Jacobs M.R., Bajaksouzian S., Zilles A., Lin G., Pankuch G.A., Appelbaum P.C. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study. Antimicrob Agents Chemother 1999; 43: 1901-1908.
Pal'chun V.T., Polyakova T.S., Nechaeva S.V., Polivoda A.M. Rol' khlamidiinoi i mikoplazmennoi infektsii v etiologii zabolevanii LOR-organov. Vestn otorinolar 2003; 4: 26-28.
Kozlov S.N., Strachunskii L.S., Rachina S.A., Tarasov A.A., Alenkina O.A., Emel'yanova L.A., Dmitrenok O.V., Dobrovol'skaya T.F., Karamysheva A.A., Kuzin V.B., Ortenberg E.A., Chemezov S.A. Analiz antibakterial'noi terapii ostrogo sinusita v ambulatornoi praktike: rezul'taty mnogotsentrovogo issledovaniya. Vestn otorinolar 2004; 6: 51-55.
Takeda H., Miura H., Kawahira M. Long-term administration study on TE-031 (A-56268) in treatment of diffuse panbronchiolitis. Kansenshogaku Zasshi 1989; 63: 71-78.
Sugiyama Y., Kitamura S., Kasahara T. Cytokines production from alveolar macrophages of rats fed by long term, low dose erythromycin. In: European Respiratory Society. Annual Congress. Berlin 1997; 432.
Tamaoki J., Takeyama K., Tagaya E. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother 1995; 39: 1688-1690.
Feshchenko Yu.I., Yashina L.A. Antibakterial'noe, protivovospalitel'noe i immunomoduliruyushchee deistvie makrolidov pri zabolevaniyakh legkikh. Zdorov`ya Ukrainy 2008; 16/1: 42-43.
Aparna, Madhu Sharma Pt.B.D., Sarita Yadav. Biofilms: microbes and disease. Braz J Infect Dis 2008; 12: 6: 526-530.
Parsek M.R., Singh P.K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
Al-Mutairi D., Kilty S.J. Bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2011; 11: 1: 18-23.
Pintucci J.P., Corno S., Garotta M. Biofilms and infections of the upper respiratory tract. Eur Rev Med Pharmacol Sci 2010; 14: 8: 683-690.
Darkes M.J.M., Perry C.M. Clarithromycin extended-release tablet: a review of its use in the managment of respiratory tract infections. Am J Respir Med 2003; 2: 175-201.
Wang J.H., Lee S.H., Kwon H.J., Jang Y.J.J. Clarithromycin inhibits rhinovirus-induced bacterial adhesions to nasal epithelial cells. Laryngoscope 2010; 12: 68-72.
Daisei Miyamoto, Sayaka Hasegawa, Nongluk Sriwilaijaroen, Sangchai Yingsakmongkon, Hiroaki Hiramatsu, Tadanobu Takahashi, Kazuya Hidari, Chao-Tan Guo, Yuichi Sakano, Takashi Suzuki, Yasuo Suzuki. Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells. Biol Pharm Bull 2008; 31: 217-222.
Brazhnik V.A. Vozmozhnosti modifitsiruyushchego vliyaniya makrolidnykh antibiotikov na techenie ostrykh respiratornykh zabolevanii, vyzvannykh virusami grippa i rinovirusami (obzor). Consilium Medicum 2010; 12: 3: 17-20.